CN105175331A - 一种egfr类分子靶向抗肿瘤药物的制备方法 - Google Patents
一种egfr类分子靶向抗肿瘤药物的制备方法 Download PDFInfo
- Publication number
- CN105175331A CN105175331A CN201510502502.9A CN201510502502A CN105175331A CN 105175331 A CN105175331 A CN 105175331A CN 201510502502 A CN201510502502 A CN 201510502502A CN 105175331 A CN105175331 A CN 105175331A
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- amino
- cyano
- preferred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DIDLAEFJEFHKJV-JXMROGBWSA-N CCOc(c(NC(/C=C/CN(C)C)=O)cc1c2Nc3cc(C)ccc3)cc1ncc2C#N Chemical compound CCOc(c(NC(/C=C/CN(C)C)=O)cc1c2Nc3cc(C)ccc3)cc1ncc2C#N DIDLAEFJEFHKJV-JXMROGBWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510502502.9A CN105175331B (zh) | 2015-08-14 | 2015-08-14 | 一种egfr类分子靶向抗肿瘤药物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510502502.9A CN105175331B (zh) | 2015-08-14 | 2015-08-14 | 一种egfr类分子靶向抗肿瘤药物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105175331A true CN105175331A (zh) | 2015-12-23 |
CN105175331B CN105175331B (zh) | 2019-04-26 |
Family
ID=54897852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510502502.9A Active CN105175331B (zh) | 2015-08-14 | 2015-08-14 | 一种egfr类分子靶向抗肿瘤药物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105175331B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111875539A (zh) * | 2020-07-15 | 2020-11-03 | 江苏苏中药业集团股份有限公司 | 一种egfr类分子靶向抗肿瘤药物的制备方法 |
CN112574173A (zh) * | 2019-09-27 | 2021-03-30 | 江苏苏中药业集团股份有限公司 | 一种杂环化合物及其制备方法与应用 |
CN112843059A (zh) * | 2019-11-27 | 2021-05-28 | 江苏苏中药业集团股份有限公司 | 一种取代丁烯酰胺的应用 |
CN115490636A (zh) * | 2021-06-18 | 2022-12-20 | 苏中药业集团股份有限公司 | 一种杂环化合物及其制备方法与应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1867564A (zh) * | 2003-10-17 | 2006-11-22 | 贝林格尔·英格海姆国际有限公司 | 氨基巴豆基化合物的制备方法 |
WO2011153942A1 (zh) * | 2010-06-09 | 2011-12-15 | 天津和美生物技术有限公司 | 氰基喹啉衍生物 |
CN102625797A (zh) * | 2009-06-25 | 2012-08-01 | 迈德药物研发技术有限公司 | 作为激酶抑制剂的取代杂环化合物及其使用方法 |
CN104513200A (zh) * | 2013-09-26 | 2015-04-15 | 江苏苏中药业集团股份有限公司 | 取代丁烯酰胺的马来酸盐及其晶型 |
-
2015
- 2015-08-14 CN CN201510502502.9A patent/CN105175331B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1867564A (zh) * | 2003-10-17 | 2006-11-22 | 贝林格尔·英格海姆国际有限公司 | 氨基巴豆基化合物的制备方法 |
CN102625797A (zh) * | 2009-06-25 | 2012-08-01 | 迈德药物研发技术有限公司 | 作为激酶抑制剂的取代杂环化合物及其使用方法 |
WO2011153942A1 (zh) * | 2010-06-09 | 2011-12-15 | 天津和美生物技术有限公司 | 氰基喹啉衍生物 |
CN104513200A (zh) * | 2013-09-26 | 2015-04-15 | 江苏苏中药业集团股份有限公司 | 取代丁烯酰胺的马来酸盐及其晶型 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112574173A (zh) * | 2019-09-27 | 2021-03-30 | 江苏苏中药业集团股份有限公司 | 一种杂环化合物及其制备方法与应用 |
CN112574173B (zh) * | 2019-09-27 | 2022-03-08 | 江苏苏中药业集团股份有限公司 | 一种杂环化合物及其制备方法与应用 |
CN112843059A (zh) * | 2019-11-27 | 2021-05-28 | 江苏苏中药业集团股份有限公司 | 一种取代丁烯酰胺的应用 |
CN111875539A (zh) * | 2020-07-15 | 2020-11-03 | 江苏苏中药业集团股份有限公司 | 一种egfr类分子靶向抗肿瘤药物的制备方法 |
CN111875539B (zh) * | 2020-07-15 | 2022-06-21 | 苏中药业集团股份有限公司 | 一种egfr类分子靶向抗肿瘤药物的制备方法 |
CN115490636A (zh) * | 2021-06-18 | 2022-12-20 | 苏中药业集团股份有限公司 | 一种杂环化合物及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105175331B (zh) | 2019-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102180868B (zh) | 抗抑郁症药物维拉佐酮的制备方法 | |
CN105175331A (zh) | 一种egfr类分子靶向抗肿瘤药物的制备方法 | |
CN102020633B (zh) | 一种1-(3,5-二氯吡啶-2-基)-吡唑甲酰胺类化合物的制备方法 | |
CN102633713A (zh) | 达比加群酯中间体及其制备方法、以及制备达比加群酯的方法 | |
JP5921235B2 (ja) | 3−ヒドロキシ−6H−ベンゾ[c]クロメン−6−オン誘導体およびその製造方法 | |
CN110526859B (zh) | 一种瑞维那新中间体及其制备方法和瑞维那新的制备方法 | |
WO2011160594A1 (zh) | 拉帕替尼的新制备方法 | |
CN101024631A (zh) | 替米沙坦的中间体及其制备与应用 | |
WO2019075976A1 (zh) | 一种制备盐酸罗沙替丁醋酸酯及中间体的方法 | |
CN103709120A (zh) | 一种盐酸阿考替胺三水合物的制备方法 | |
CN103288808B (zh) | 一种阿法替尼的制备方法 | |
CN101717359A (zh) | 吲达帕胺的合成方法 | |
CN103864773B (zh) | 利伐沙班及其中间体的制备方法 | |
CN103059047B (zh) | 一种制备头孢唑肟丙匹酯盐酸盐的方法 | |
CN112574087B (zh) | 一种3-氨基吡咯烷盐酸盐的合成方法 | |
CN105777581A (zh) | 一种顺-1-腈基-4-甲氧基环己基-2-(2,5-二甲基苯基)乙酰胺及其制备方法和应用 | |
WO2022152315A1 (zh) | 一种合成氨基嘧啶类fak抑制剂化合物的方法 | |
CN106892932A (zh) | 一种非甾体抗炎镇痛药氯诺昔康的制备方法 | |
CN100486977C (zh) | 雷莫司琼的一种新制备方法 | |
CN101585773B (zh) | 一种n,n-二丙基-2-(2-甲基-3-硝基苯基)-乙胺盐酸盐的制备方法 | |
CN107722007B (zh) | 阿哌沙班杂质的制备方法 | |
CZ304887B6 (cs) | Způsob přípravy derivátů arylethanoldiaminu | |
CN108623577B (zh) | 阿莫奈韦及其中间体的制备方法 | |
CN103360343A (zh) | 一种哌嗪酰胺类化合物的制备方法 | |
CN102858739A (zh) | 酰胺化吡咯甲酸酯化合物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200508 Address after: 225500 No. 1 Su Zhong Road, Taizhou, Jiangsu Co-patentee after: NANJING SUZHONG PHARMACEUTICALS RESEARCH Co.,Ltd. Patentee after: Jiangsu Suzhong Pharmaceutical Group Co.,Ltd. Address before: 225500 No. 1 Su Zhong Road, Taizhou, Jiangsu Patentee before: Jiangsu Suzhong Pharmaceutical Group Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 225500 No. 1 Suzhong Road, Taizhou City, Jiangsu Province Patentee after: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. Patentee after: Jiangsu Suzhong Pharmaceutical Research Institute Co.,Ltd. Address before: 225500 No. 1 Suzhong Road, Taizhou City, Jiangsu Province Patentee before: Jiangsu Suzhong Pharmaceutical Group Co.,Ltd. Patentee before: NANJING SUZHONG PHARMACEUTICALS RESEARCH Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address |
Address after: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee after: Suzhong Pharmaceutical Group Co.,Ltd. Patentee after: Jiangsu Suzhong Pharmaceutical Research Institute Co.,Ltd. Address before: 225500 No. 1 Suzhong Road, Taizhou City, Jiangsu Province Patentee before: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: Jiangsu Suzhong Pharmaceutical Research Institute Co.,Ltd. |
|
CP03 | Change of name, title or address |